Garrett M. Brodeur, MD, is the Director of the Cancer Predisposition Program at CHOP and Associate Director of the Abramson Cancer Center at Penn. He has a special interest in the molecular biology, genetics and targeted therapy of neuroblastoma.
Areas of Expertise:
Neuroblastoma, Cancer predisposition, Targeted cancer therapy, Nanoparticle drug delivery
Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)